Compliance with treatment regimens in chronic asymptomatic diseases

American Journal of Medicine

Volumn 102, Issue 2 A, 1997, Pages 43-49

  Miller, Nancy Houston ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR MODIFICATION; CHRONIC DISEASE; DOCTOR PATIENT RELATION; HUMAN; LIFESTYLE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW;

EID: 0030889653     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00467-1     Document Type: Article

References (49)

1. Emerging issues in pharmaceutical cost containment. Reston, VA: National Pharmaceutical Council, 1992;2:1-16.
2. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Annals of Pharmacotherapy. 1993;27(suppl):S5-S24.
3. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
4. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290-1295.
5. Donovan JL. Patient decision making: the missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443-455.
6. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J. 1995;130:572-579.
7. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100:258-268.
8. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
9. Glanz K. Compliance with dietary regimens: its magnitude, measurement, and determinants. Prev Med. 1980;9:787-804.
10. Oldridge NB. Compliance with cardiac rehabilitation services. J Cardiopulm Rehabil. 1991;11:115-127.
11. Dishman RK. Compliance/adherence in health-related exercise. Health Psychol. 1982;1:237-267.
12. Haynes RB, Taylor DW, Sackert DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979.
13. Morris LS, Schulz RM. Medication compliance: the patient's perspective. Clin Ther. 1993;15:593-606.
14. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med. 1985;20:29-37.
15. Berg JS, Dischler J, Wagner DJ, et al. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27(suppl):S1-S24.
16. Survey by Applied Research Techniques Conducted for the American Association of Retired Persons. Washington DC: American Association of Retired Persons, 1984.
17. National Prescription Buyers Survey. Kalamazoo MI: The Upjohn Company, 1985.
18. Rudd P, Ahmed S, Zachary V, et al. Compliance with medication timing: implications from a medication trial for drug development and clinical practice. J Clin Res Pharmacoepidemiol. 1992;6:15-27.
19. Kruse WH. Compliance with treatment of hyperlipiproteinemia in medical practice and clinical trials. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, Ltd, 1991:175-186.
20. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spiker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991:123-137.
21. Hasford J. Compliance and the benefit/risk relationship of antihypertensive treatment. J Cardiovasc Pharmacol. 1992;20(suppl 6):S30-S34.
22. Caldwell JR, Cobb S, Dowling MD, De Jongh D. The dropout problem in antihypertensive treatment. J Chron Dis. 1970:22:579-592.
23. Basler HD, Weissbach I. Diagnostik der Medikamenten - Compliance durch Befragung des Patienten - eine Untersuchung an essentiellen Hypertonikern. Psychother Med Psychol. 1984;34:331-335.
24. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalization of the elderly. Arch Intern Med. 1990;150:841-845.
25. Parkin DM, Henney CR, Quirk J, Crooks J. Deviation from prescribed drug treatment after discharge from hospital. Br Med J. 1976;2:686-688.
26. Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995;56(suppl 1):18-22.
27. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984; 251:365-374.
28. Urquhart J. Correlates of variable patient compliance in drug trials: relevance in the new health care environment. Adv Drug Res. 1995; 26:237-257.
29. Psaty BM, Koepsell TD, Wagner EH, et al. The relative risk of incident coronary heart disease associated with recently stopping the use of β-blockers. JAMA. 1990;263:1653-1657.
30. Hill MN, Miller NH. Compliance enhancement: a call for multidisciplinary team approaches. Circulation. 1996;93:4-6.
31. Dunbar-Jacob J, Dwyer K, Dunning EJ. Compliance with antihypertensive regimen: a review of the research in the 1980's. Soc Behav Med. 1991;13:31-39.
32. Hussey LC. Minimizing effects of low literacy on medication knowledge and compliance among the elderly. Clinical Nursing Res. 1994; 3:132-145.
33. Svarstad BL. Physician-patient communication and patient conformity with medical advice. In: Mechanic D, ed. The Growth of Bureaucratic Medicine: An Inquiry Into the Dynamics of Patient Behavior and the Organization of Medical Care. New York: John Wiley and Sons, 1976:220-238.
34. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.
35. Rudd P. Maximizing compliance with antihypertensive therapy. Drug Ther. 1992;December:25-32.
36. Haynes RB, Wang E, Da Mota Gomes M. A critical review of interventions to improve compliance with prescribed medications. Patient Education and Counseling. 1987;10:155-166.
37. Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;i:1265-1268.
38. Logan AG, Milne BJ, Achber C, et al. Work-site treatment of hypertension by specially trained nurses. A controlled trial. Lancet. 1979;ii:1175-1178.
39. Miller NH, Taylor CB. Lifestyle Management for Patients with Coronary Heart Disease. Current Issues in Cardiac Rehabilitation, Monograph Number 2. Champaign, IL: Human Kinetics, 1995.
40. Kirscht JP, Kirscht JL, Rosenstock IM. A test of interventions to increase adherence to hypertensive medical regimens. Health Educ Q. 1981;8:261-272.
41. Pratt JH, Jones JJ. Noncompliance with therapy: an ongoing problem in treating hypertension. Primary Cardiology. 1995;21:34-38.
42. Becker MH. Patient adherence to prescribed therapies. Medical Care. 1985;23:539-555.
43. Sharkness CM, Snow DA. The patient's view of hypertension and compliance. Am Prev Med. 1992;8:141-146.
44. Luepker RV. Patient adherence: a "risk factor" for cardiovascular disease. Heart Disease and Stroke. 1993;2:418-421.
45. Moser M. Noncompliance in the management of hypertension: a different perspective. Primary Cardiology. 1995;21:3-4.
46. Wright EC. Non-compliance - or how many aunts has Matilda? Lancet. 1993;342:909-913.
47. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24:67-74.
48. DeBusk RF, Houston Miller N, Superko R, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120:721-729.
49. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.